Literature DB >> 15576666

Albumin is not an irreplaceable carrier for amphipathic mediators of thermoregulatory responses to LPS: compensatory role of alpha1-acid glycoprotein.

Andrei I Ivanov1, Alexandre A Steiner, Shreya Patel, Alla Y Rudaya, Andrej A Romanovsky.   

Abstract

In view of the potential involvement of peripherally synthesized, circulating amphipathic mediators [such as platelet-activating factor (PAF) and prostaglandin E(2)] in the systemic inflammatory response to lipopolysaccharide (LPS), we hypothesized that transport of amphipaths by albumin is essential for conveying peripheral inflammatory signals to the brain. Our first specific aim was to test this hypothesis by studying LPS-induced fever and hypothermia in Nagase analbuminemic rats (NAR). NAR from two different colonies and normalbuminemic Sprague-Dawley rats were preimplanted with jugular catheters, and their febrile responses to a mild dose of LPS (10 microg/kg i.v.) at thermoneutrality and hypothermic responses to a high dose of LPS (500 microg/kg i.v.) in the cold were studied. NAR of both colonies developed normal febrile and hypothermic responses, thus suggesting that transport of amphipathic mediators by albumin is not indispensable for LPS signaling. Although alternative carrier proteins [such as alpha(1)-acid glycoprotein (AGP)] are known to assume transport functions of albumin in NAR, it is unknown whether inflammatory mediators are capable of inducing their actions when bound to alternative carriers. To test whether PAF, the most potent amphipathic pyrogen, causes fever when administered in an AGP-bound form was our second aim. Sprague-Dawley rats were preimplanted with jugular catheters, and their thermal responses to infusion of a 1:1 [PAF-AGP] complex (40 nmol/kg i.v.), AGP (40 nmol/kg i.v.), or various doses of free (aggregated) PAF were studied. The complex, but neither free PAF nor AGP, caused a high ( approximately 1.5 degrees C) fever with a short (< 10 min) latency. This is the first demonstration of a pyrogenic activity of AGP-bound PAF. We conclude that, in the absence of albumin, AGP and possibly other carriers participate in immune-to-brain signaling by binding and transporting amphipathic inflammatory mediators.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15576666     DOI: 10.1152/ajpregu.00514.2004

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  6 in total

Review 1.  Leptin: at the crossroads of energy balance and systemic inflammation.

Authors:  Alexandre A Steiner; Andrej A Romanovsky
Journal:  Prog Lipid Res       Date:  2006-12-21       Impact factor: 16.195

2.  Aging reverses the role of the transient receptor potential vanilloid-1 channel in systemic inflammation from anti-inflammatory to proinflammatory.

Authors:  Samuel P Wanner; Andras Garami; Eszter Pakai; Daniela L Oliveira; Narender R Gavva; Cândido C Coimbra; Andrej A Romanovsky
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

3.  Cellular and molecular bases of the initiation of fever.

Authors:  Alexandre A Steiner; Andrei I Ivanov; Jordi Serrats; Hiroshi Hosokawa; Allison N Phayre; Jared R Robbins; Jennifer L Roberts; Shigeo Kobayashi; Kiyoshi Matsumura; Paul E Sawchenko; Andrej A Romanovsky
Journal:  PLoS Biol       Date:  2006-09       Impact factor: 8.029

4.  Hyperbilirubinemia exaggerates endotoxin-induced hypothermia.

Authors:  Eszter Pakai; Andras Garami; Tatiane B Nucci; Andrei I Ivanov; Andrej A Romanovsky
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  Platelet-activating factor is a potent pyrogen and cryogen, but it does not mediate lipopolysaccharide fever or hypothermia.

Authors:  Alexandre A Steiner; Andrej A Romanovsky
Journal:  Temperature (Austin)       Date:  2015-05-15

6.  Kukoamine B promotes TLR4-independent lipopolysaccharide uptake in murine hepatocytes.

Authors:  Dong Yang; Xinchuan Zheng; Ning Wang; Shijun Fan; Yongjun Yang; Yongling Lu; Qian Chen; Xin Liu; Jiang Zheng
Journal:  Oncotarget       Date:  2016-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.